5Paisa Capital Limited has informed the Exchange about change in Management
5PAISA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
5Paisa Capital Limited has appointed Dr. Sarat Kumar Malik (DIN: 09791314) as an Additional Non-Executive Independent Director with effect from July 8, 2025. He will serve for an initial term of five years, subject to shareholder approval at the next general meeting. Dr. Malik holds a Ph.D. in Economics and an M.A. from JNU, with over 30 years of experience across the financial sector, securities markets, and banking. He has previously worked with regulatory bodies including SEBI, RBI, IICA, the World Bank, and the IMF, and has contributed to policy advisory groups on capital markets and fintech. The appointment was recommended by the Nomination and Remuneration Committee and approved by the Board. Dr. Malik is not related to any existing director and has not been debarred from holding directorship by any authority.
The appointment strengthens the board with an independent director who brings deep regulatory and policy expertise from SEBI, RBI, and global institutions, which could bolster governance and compliance oversight. For shareholders, this is a routine board-level change and is unlikely to have an immediate material impact on stock price or operations.